Fadhel S. Shaheen

发表

The occurrence and associated risk factors of brain metastases in well differentiated grade 1 and 2 bronchial neuroendocrine tumours: A single centre retrospective analysis of 280 patients

J. Weaver, G. Papaxoinis, K. Rammohan, 2022, Journal of neuroendocrinology.

Abstract 3848: Preclinical profile of AZD3514: A small molecule-targeting androgen receptor function with a novel mechanism of action and the potential to treat castration-resistant prostate cancer

A. Rabow, C. Robson, G. Walker, 2012 .

Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer

N. Curtin, R. Plummer, C. Robson, 2011, PLoS ONE.

AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo

Rhys D O Jones, A. Rabow, S. Barry, 2013, Molecular Cancer Therapeutics.

Small Molecule Therapeutics AZD 3514 : A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo

Rhys D O Jones, A. Rabow, S. Barry, 2013 .

Regulation of the androgen receptor by SET9-mediated methylation

C. Robson, I. McEwan, Chenguang Wang, 2010, Nucleic acids research.

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.

Paul Cross, C. Robson, R. Edmondson, 2012, Gynecologic oncology.

Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells

C. Robson, J. Lunec, I. Logan, 2016, Oncotarget.